Keyphrases
Abnormal Uterine Bleeding
100%
Polycystic Ovary Syndrome
85%
Spain
68%
Hyperprolactinemia
61%
Clinical Practice
59%
Raloxifene
55%
Prolactin
53%
Testosterone
49%
Quality of Life
43%
Menstrual Blood Loss
41%
NOMAC-E2
39%
Combined Oral Contraceptives
39%
Contraceptive Use
39%
Postpartum Contraception
39%
Fibroids
39%
Betamimetics
39%
Selective Estrogen Receptor Modulators
39%
Gonadotropins
34%
Estrogen
33%
Hirsutism
32%
Fetus
31%
Ethinylestradiol
30%
Insulin
28%
Chromosomal Instability
27%
Third Generation
27%
Hyperandrogenism
26%
Gynecologist
26%
Levonorgestrel
25%
Breast Cancer
25%
Obstetrics
24%
Insulin Resistance
24%
Gonadotropin-releasing Hormone
23%
Unprotected Sex
23%
Clinical Trials
23%
Postmenopausal Women
23%
Sex Hormone-binding Globulin
21%
Androstenedione
21%
Clinical Perspective
21%
Hyperinsulinism
21%
Breast
21%
Menopause
21%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
21%
Clinical Data
20%
Assisted Reproductive Technology
20%
Intrauterine Insemination
19%
Female Reproductive Health
19%
Intrapartum Risk Factors
19%
Weight Decrease
19%
Spinal muscular Atrophy
19%
Metabolic Syndrome
19%
Pharmacology, Toxicology and Pharmaceutical Science
Menorrhagia
98%
Levonorgestrel
79%
Prolactin
62%
Raloxifene
61%
Ethinylestradiol
60%
Hyperprolactinemia
59%
Bleeding
53%
Androgen
52%
Selective Estrogen Receptor Modulator
49%
Breast Cancer
44%
Liquefied Natural Gas
41%
Oral Contraceptive Agent
41%
Gonadotropin
34%
Combination Therapy
30%
Bisphosphonic Acid Derivative
29%
Disease
29%
Clinical Trial
28%
Dopamine Receptor Stimulating Agent
27%
Hyperandrogenism
26%
Intrauterine Device
26%
Prolactinoma
23%
Hyperinsulinism
23%
Androstenedione
23%
Insulin Resistance
23%
Venous Thromboembolism
23%
Acne
22%
Contraceptive Agent
22%
Testosterone
19%
Sex Hormone Binding Globulin
19%
Luteinizing Hormone
19%
Oral Contraceptive
19%
High Risk Pregnancy
19%
Premature Labor
19%
Receptor
19%
Coronavirinae
19%
Progesterone
19%
Anemia
19%
Metoclopramide
19%
Iron Deficiency Anemia
19%
Diethylstilbestrol
19%
Amenorrhea
19%
Growth Hormone
19%
Pregnancy Diabetes Mellitus
19%
Ovary Tumor
19%
Ulipristal
19%
Prospective Study
19%
Neonatal Respiratory Distress Syndrome
19%
Cyproterone
19%
Ovary Polycystic Disease
19%
Postmenopause Osteoporosis
19%
Medicine and Dentistry
Menorrhagia
95%
Polycystic Ovary Syndrome
59%
Levonorgestrel
58%
Androgen
49%
Obstetrics
45%
Quality of Life
42%
Liquefied Natural Gas
41%
Oral Contraceptive Agent
41%
Gonadotropin
34%
Observational Study
34%
Bleeding
33%
Hirsutism
32%
Uterine Fibroid
29%
Magnetic Resonance Imaging
29%
Ethinylestradiol
29%
Testosterone
27%
Hyperandrogenism
26%
Insulin Resistance
26%
Reproductive Medicine
24%
Prolactinoma
23%
Hyperinsulinism
23%
Androstenedione
23%
Prolactin
23%
Acneiform Eruption
22%
Clinician
22%
Postmenopause
22%
Intrauterine Device
22%
Hyperprolactinemia
21%
Neoplasm
20%
Hazard Ratio
19%
Emergency Contraception
19%
Prevalence
19%
Body Weight Loss
19%
Gestational Diabetes
19%
Cohort Effect
19%
Insemination
19%
Growth Hormone
19%
Unwanted Pregnancy
19%
Vagina Smear
19%
Glucose Metabolism
19%
Hypochromic Anemia
19%
Health Care Cost
19%
Fetus Lung Maturation
19%
Spinal Muscular Atrophy
19%
Retrograde Ejaculation
19%
Supplementation
19%
Ovarian Tumor
19%
Birth Rate
19%
Microscopy
19%
Clinical Trial
19%
